Bill Title: To amend the Federal Food, Drug, and Cosmetic Act to provide for the development and use of patient experience data to enhance the structured risk-benefit assessment framework, and for other purposes.

Sponsorship: Partisan Bill (Republican 1)

Status: (Introduced - Dead) 2015-05-15 - Referred to the Subcommittee on Health. [HB2338 Detail]

Text: Latest bill text (Introduced) [PDF]

---

PolitiCorps Conversations

Start PolitiCorps Debate

Title	PolitiCorps	Access	Comments	Views	Last Post
There are no visible public or private PolitiCorps discussions concerning the 2015 US Congress HB2338 at this time.